Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia

NCT04414930 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT04414930
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04414930 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Completed
Start date
November 9, 2020
Completion date
December 30, 2024
Enrollment
68 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia